<DOC>
	<DOCNO>NCT01530620</DOCNO>
	<brief_summary>The purpose clinical study compare efficacy safety propiverine hydrochloride extend immediate release formulation patient suffer neurogenic detrusor overactivity .</brief_summary>
	<brief_title>Efficacy Tolerability Propiverine Hydrochloride Patients With Neurogenic Detrusor Overactivity</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Urinary Bladder , Neurogenic</mesh_term>
	<mesh_term>Urologic Diseases</mesh_term>
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Urinary Bladder Diseases</mesh_term>
	<mesh_term>Propiverine</mesh_term>
	<criteria>Male female Caucasian patient age ≥18 ≤70 year Voluntarily sign informed consent Neurogenic detrusor overactivity occurrence reflex detrusor contraction Reflex volume ≤250 mL Intact reflex arcs area segment S2S4 Patients suffer multiple sclerosis unstable condition Augmented reflex bladder Patients increase residual urine ( ≥20 % maximum bladder capacity ) , catheterization possible Acute urinary tract infection Electrostimulation therapy ( within 4 week propir Visit 1 ) Anomalies low genitourinary tract ( e.g . ectopic ureter , fistula , urethral stenosis ) Radiation bladder , interstitial cystitis , bladder calculus , bladder carcinoma Surgery low genitourinary tract within last 6 month ( e.g . prostatectomy , hysterectomy , tumor surgery ) Preexisting medical contraindication anticholinergic Cardiac insufficiency ( NYHA stage III/ IV ) Therapy botulinum toxin within last 12 month Evidence severe renal , hepatic metabolic disorder History drug alcohol abuse Concomitant medication know potential interfere trial medication Known hypersensitivity Propiverine hydrochloride excipients contain trial medication , respectively Pregnant breastfeed woman , woman childbearing potential without use reliable contraceptive method Patients impaired cooperation unable understand nature , scope possible consequence study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Antimuscarinics</keyword>
	<keyword>Neurogenic bladder</keyword>
	<keyword>Propiverine</keyword>
	<keyword>Urodynamics</keyword>
</DOC>